From April 1, 2022 to June 30, 2022, the company has repurchased 0 shares, representing 0% for KRW 0 million. With this, the company has completed the repurchase of 574,608 shares, representing 1.99% for KRW 24,180.98 million under the buyback announced on February 9, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
36,150 KRW | +0.42% |
|
-3.60% | -18.67% |
06-19 | IMBiologics Signs $964 Million Licensing Deal for Autoimmune Treatments | MT |
04-04 | Protium Science Co.,Ltd. announced that it has received KRW 2 billion in funding from HK inno.N Corporation | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-18.67% | 742M | |
+5.86% | 71.83B | |
+23.57% | 9.56B | |
+30.09% | 4.85B | |
-21.31% | 4.48B | |
+24.78% | 3.9B | |
+11.03% | 2.01B | |
-1.01% | 1.99B | |
-36.28% | 1.89B | |
-43.19% | 1.77B |
- Stock Market
- Equities
- A195940 Stock
- News HK inno.N Corporation
- Tranche Update on HK inno.N Corporation's Equity Buyback Plan announced on February 9, 2022.